Project Grant R21AG086865
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$446K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45267, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) is funding research on the role of Protease Activated Receptor 2 (PAR2) in the initiation and progression of abdominal aortic aneurysm (AAA). The $740,338 award to the University of Cincinnati will support a 4-year research project to determine the effect of VSMC-specific PAR2 deletion and pharmacological PAR2 inhibition in mouse models of...
The University of Massachusetts Medical School was awarded a $460,625 Project Grant by the National Institute on Aging (CFDA 93.866 - Aging Research) to investigate the role of platelet-MLKL in S100 release with age and infection. The project aims to determine how platelet-MLKL channel formation, mediated by influenza virus, leads to cytoplasmic S100 content release and contributes to immunothrombosis in older adults. The research will focus on elucidating the mechanisms that may increase...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research supports a $169,560 research project to investigate the molecular mechanisms underlying abdominal aortic aneurysm (AAA) development. The awardee, Regents of the University of Michigan, will elucidate the impact of endoplasmic reticulum (ER) stress response signaling via PERK/EIF2A/ATF4 on vascular smooth muscle cell (VSMC) apoptosis in human and murine AAAs....
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $779,952 to Thomas Jefferson University's Sidney Kimmel Medical College to conduct research on the role of platelets in remote organ injury and infection after ischemic stroke. The key objectives are to: 1) elucidate how activated platelets contribute to remote organ injury and infection following ischemic stroke/reperfusion; 2) determine which platelet components...
This federal Project Grant award, with a total funding amount of $153,252, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will support a 3-year research program focused on elucidating the molecular mechanisms and clinical significance of a specific macrophage population (SPP1+ macrophages) in peripheral arterial disease (PAD). The primary objectives are to determine if SPP1+ macrophages inhibit...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $573,261 to the University of Rochester to investigate the role of platelet-monocyte interactions in regulating immune responses and inflammation. The key aims are to determine: 1) the signaling mechanisms by which resting platelets "immune train" monocytes to a quiescent state, 2) the functional outcomes of this...
This federal Project Grant award of $416,625 from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), will support research at Saint Louis University (SLU) to investigate the effects of aging, sex, and hormonal status on atherosclerotic cardiovascular disease (CVD). The key objectives are to: 1) comprehensively map inflammatory cell profiles and cell-cell communication networks in atherosclerotic plaques of young and old male and female mice, including old...
This Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $10,847,672 to the J. David Gladstone Institutes, a non-profit biomedical research organization, to investigate the vascular-immune mechanisms underlying cerebral amyloid angiopathy (CAA) and Alzheimer's disease pathology. The research aims to elucidate the key microglial mechanisms regulating the formation of vascular CAA versus parenchymal amyloid-beta plaques, define single-cell and...
This federal Project Grant award of $1,127,798 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to understand the role of macrophages in preserving cardiovascular health and their contributions to cardiovascular disease (CVD). The overarching goal is to identify new therapeutic targets for CVD in both female and male patients. The research will use advanced single cell imaging and omics techniques to characterize harmful...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,419,308 to the University of Pittsburgh to investigate the mechanisms linking persistent DNA damage to the upregulation of NLRP12 and the functional links between persistent DNA damage and NLRP12 in aging hematopoiesis. The award period is from Sep 17, 2024 to Aug 31, 2025. The research aims to elucidate a novel interplay between...